Neuphoria Therapeutics Inc. (NEUP)

3.76 -0.27% (-0.01)

Over 6M: -11.7%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

4 5
Mar Apr May Jun Jul Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q4 '25 — Revenue: -13.3K Q1 '26 — Net Income: -9.9M Q2 '26 — Net Income: 1.9M Q3 '26 — Net Income: -505.1K -7.5M -5M -2.5M 0 2.5M
Q4 '25 Q1 '26 Q2 '26 Q3 '26
Revenue Free Cash Flow Net Income

Figures as at 2025-06-30, reported in USD. The newest fact in the filings is dated 2026-03-31, 152 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.3
OE margin -112.0%
Oper. margin -107.1%
ROIC -132.6%
Accruals 48.2%
EBITDA margin -102.9%
FCF margin -109.6%
OCF margin -109.6%
ROA -1.1%
ROCE -50.3%
ROE -1.3%
Capex / sales —
Gross margin —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

0.5
RPO / sales —
RPO growth —
Segment HHI —

0 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
Current ratio 14.3×
ND/EBITDA —
Interest cover -961.4×
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 14.3×
Cash runway 1.1 yr
Cash / Debt —
F-score —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Shares change +95.1%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —
Sales/sh Y/Y —

1 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.